Form 4: Amedisys Director Klapstein Receives Stock Units

Director Julie D. Klapstein of Amedisys Inc. was awarded 1,690 restricted stock units on May 3, 2025, which will vest on May 3, 2026, contingent upon continued service on the Board of Directors.

Summary

• On May 3, 2025, Julie D. Klapstein, a director of Amedisys Inc., received 1,690 time-based Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Amedisys' common stock.
• The RSUs will vest 100% on May 3, 2026, provided Klapstein continues to serve as a non-employee member of the Issuer's Board of Directors through that date.
• Following the transaction, Klapstein directly owns 16,031 shares of Amedisys common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction of awarding stock units to a director, which is generally viewed positively as it aligns interests. There are no indications of negative news or concerns.

Positives

• The awarding of restricted stock units to a director aligns their interests with those of the shareholders.
• Continued service requirement encourages long-term commitment from the director.

Future Outlook

The vesting of the RSUs is contingent upon Klapstein's continued service as a director, incentivizing her ongoing involvement with Amedisys.

Industry Context

Stock grants to board members are a common practice in publicly traded companies to align the interests of directors with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Equity compensation for board members is a standard practice across the healthcare industry.
• Companies like LHC Group and Option Care Health also utilize stock grants and options as part of their director compensation packages.
• The size of the grant is typical for non-executive directors in similar-sized healthcare companies.

Stakeholder Impact

• Shareholders may view the stock grant positively as it aligns the director's interests with the company's long-term success.
• The director is incentivized to continue contributing to the company's governance and strategic direction.

Key Dates

Keywords

Amedisys, Director, Klapstein, Restricted Stock Units, RSU, Beneficial Ownership, Form 4, Securities